George Altirs 12/11/24 George Altirs 12/11/24

Abstractive Health

AI Medical Record Summarization

Mark Roehrenbeck 7/14/21 Mark Roehrenbeck 7/14/21

Aluna

Connected Health

Mark Roehrenbeck 7/12/21 Mark Roehrenbeck 7/12/21

Anacor

Biotech for infectious and inflammatory diseases

Mark Roehrenbeck 7/6/21 Mark Roehrenbeck 7/6/21

Aquesys

Glaucoma treatment

Mark Roehrenbeck 6/21/21 Mark Roehrenbeck 6/21/21

Cara

Biotech for pain and inflation

Mark Roehrenbeck 5/27/21 Mark Roehrenbeck 5/27/21

Dendreon

Biotech for prostate cancer

Mark Roehrenbeck 5/21/21 Mark Roehrenbeck 5/21/21

Dyax

Biotech for cancer

Mark Roehrenbeck 4/27/21 Mark Roehrenbeck 4/27/21

Gloucester Pharmaceuticals

Pharma for cell lymphoma

George Altirs 4/25/21 George Altirs 4/25/21

Huma

Platform for Digital and AI-first Healthcare Products

Mark Roehrenbeck 4/24/21 Mark Roehrenbeck 4/24/21

Human Genome Sciences

Biotech treating lupus, hepatitis C, inhalation anthrax and cancer.

Mark Roehrenbeck 4/3/21 Mark Roehrenbeck 4/3/21

Medical Present Value

Revenue cycle management for healthcare providers

Mark Roehrenbeck 3/30/21 Mark Roehrenbeck 3/30/21

Mersana

Biotech for oncology

Mark Roehrenbeck 3/27/21 Mark Roehrenbeck 3/27/21

NGM Bio

Biotech for metabolic diseases

Mark Roehrenbeck 3/12/21 Mark Roehrenbeck 3/12/21

Pharmavene

Drug delivery and screening technology

Mark Roehrenbeck 3/6/21 Mark Roehrenbeck 3/6/21

PHT

Electronic patient reported outcome (ePro) solutions for clinical trials

Mark Roehrenbeck 2/21/21 Mark Roehrenbeck 2/21/21

Sarcode

Biotech for ophthalmic diseases

Mark Roehrenbeck 2/9/21 Mark Roehrenbeck 2/9/21

Senomyx

Biotech focused on taste receptors

Mark Roehrenbeck 1/20/21 Mark Roehrenbeck 1/20/21

Toothio

On demand staffing for dental industry

Mark Roehrenbeck 1/15/21 Mark Roehrenbeck 1/15/21

Vanda

Biotech for central nervous system disorders